Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
| العنوان: | Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy |
|---|---|
| المؤلفون: | Priyoshi Lahiri, Christopher Horton, Paul J. Fairchild, Patty Sachamitr, Timothy J. Davies |
| المصدر: | Stem Cells (Dayton, Ohio) |
| بيانات النشر: | Oxford University Press (OUP), 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | 0301 basic medicine, induced pluripotent stem cell, dendritic cell, Induced Pluripotent Stem Cells, Embryonic Stem Cells/Induced Pluripotent Stem Cells, Kruppel-Like Factor 4, Mice, 03 medical and health sciences, 0302 clinical medicine, SOX2, Animals, Humans, immunostimulation, Induced pluripotent stem cell, MHC class II, biology, maturation, epigenetic memory, Cell Differentiation, Dendritic Cells, Cell Biology, Dendritic cell, Cellular Reprogramming, Phenotype, Embryonic stem cell, Cell biology, 030104 developmental biology, KLF4, biology.protein, Molecular Medicine, Immunotherapy, Reprogramming, 030217 neurology & neurosurgery, Developmental Biology |
| الوصف: | Cell types differentiated from induced pluripotent stem cells (iPSCs) are frequently arrested in their development program, more closely resembling a fetal rather than an adult phenotype, potentially limiting their utility for downstream clinical applications. The fetal phenotype of iPSC‐derived dendritic cells (ipDCs) is evidenced by their low expression of MHC class II and costimulatory molecules, impaired secretion of IL‐12, and poor responsiveness to conventional maturation stimuli, undermining their use for applications such as immune‐oncology. Given that iPSCs display an epigenetic memory of the cell type from which they were originally derived, we investigated the feasibility of reprogramming adult DCs to pluripotency to determine the impact on the phenotype and function of ipDCs differentiated from them. Using murine bone marrow‐derived DCs (bmDCs) as proof of principle, we show here that immature DCs are tractable candidates for reprogramming using non‐integrating Sendai virus for the delivery of Oct4, Sox2, Klf4, and c‐Myc transcription factors. Reprogramming efficiency of DCs was lower than mouse embryonic fibroblasts (MEFs) and highly dependent on their maturation status. Although control iPSCs derived from conventional MEFs yielded DCs that displayed a predictable fetal phenotype and impaired immunostimulatory capacity in vitro and in vivo, DCs differentiated from DC‐derived iPSCs exhibited a surface phenotype, immunostimulatory capacity, and responsiveness to maturation stimuli indistinguishable from the source DCs, a phenotype that was retained for 15 passages of the parent iPSCs. Our results suggest that the epigenetic memory of iPSCs may be productively exploited for the generation of potently immunogenic DCs for immunotherapeutic applications. The phenotype and function of dendritic cells (DCs) differentiated from induced pluripotent stem cells (iPSCs) is profoundly influenced by the cell type of origin. iPSCs reprogrammed from mouse embryonic fibroblasts yield poorly immunogenic DCs, consistent with a “fetal” phenotype. In contrast, reprogramming of immature mouse DCs to pluripotency captures an epigenetic memory that supports the differentiation of highly stimulatory DCs, suitable for downstream immunotherapy. |
| تدمد: | 1549-4918 1066-5099 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c588af8163bdea20b958a86fdfad320f https://doi.org/10.1002/stem.3095 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....c588af8163bdea20b958a86fdfad320f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15494918 10665099 |
|---|